Blog Archives
Federal Jury Awards Walgreens Pharmacist $1.2 Million in Medicare Billing Fraud Case
J&J Says Agreement Reached in Criminal Risperdal Promotion Case
Connecticut Hospital Settles Charges of Overbilling Medicare for Prostate Drug
DOJ Intervenes in Suit Over Clinic’s Alleged Improper Billing for Sleep Disorder Tests
Prosecutors See Case Shift From Pharma To Devices, Park Doctrine Cases Coming
Alleged Kickbacks for Using Medical Devices Set Stage for FCA Suit Against Manufacturer
Maker of Epilepsy Drug Pleads Guilty In Off-Label Case, Resolves FCA Charges
High Court Rules Data From FOIA Request Constitutes Public Disclosure Under False Claims Act
In a ruling with implications for the health care industry, the U.S. Supreme Court May 16 ruled that information gathered through Freedom of Information Act (FOIA) requests constituted “public disclosures” and precluded recovery…
Read more here:
Drugmaker Serono Agrees to Pay $44.3 Million to Settle Fraud Charges
Pharmaceutical manufacturer EMD Serono Inc. has agreed to pay $44.3 million to settle allegations it paid providers kickbacks to induce them to prescribe or promote its multiple sclerosis drug Rebif and that these payments resulted in the…
Read more here:
SEC cool to corporate demands on whistleblowers
(Reuters) – U.S. securities regulators are resisting corporate America’s demands to force whistleblowers to report possible wrongdoing internally before they can be considered for compensation from regulators. The Securities and Exchange Commission’s whistleblower proposal, one of many rules required by the Dodd-Frank Wall Street overhaul law, would financially reward people who provide original substantive tips leading to enforcement actions that result in sanctions exceeding $1 million.
Read more at Reuters